Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,313-9,324 of 23,847
Drug study icon
CompletedNCT00566631

Paliperidone Extended-Release (ER) Tablets for schizophrenia

This study is completed in France, in Croatia, in Germany, .... It is testing Paliperidone Extended-Release (ER) Tablets for schizophrenia.

Multiple locations, including Zagreb
SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
France, Croatia, Germany, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Drug study icon
CompletedNCT01299389

Paliperidone Palmitate for schizophrenia

This study is completed in Japan, in South Korea, and in Taiwan. It is testing paliperidone Palmitate for schizophrenia.

Multiple locations, including Fujioka
SchizophreniaDrugOver 20 Years
Countries
Japan, South Korea, Taiwan
Sponsor
Janssen Pharmaceutical K.K.
Condition
Schizophrenia
Drug study icon
CompletedNCT02473289

Sirukumab for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing sirukumab for depression.

Multiple locations, including Birmingham
DepressionDrugFrom 21 Years to 64 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02498392

Safety study of JNJ-42165279 in depression

This study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-42165279 for depression.

Multiple locations, including Costa Mesa
Depression, AnxietyDrugFrom 18 Years to 64 Years
Countries
United States, United Kingdom, Moldova, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.